230 related articles for article (PubMed ID: 9763605)
21. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
[TBL] [Abstract][Full Text] [Related]
22. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
Burdo TH; Gartner S; Mauger D; Wigdahl B
J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
[TBL] [Abstract][Full Text] [Related]
23. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
[TBL] [Abstract][Full Text] [Related]
24. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
Smith CD; Baglia LA; Curristin SM; Ruddell A
J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
[TBL] [Abstract][Full Text] [Related]
25. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages.
Emori Y; Ikeda T; Ohashi T; Masuda T; Kurimoto T; Takei M; Kannagi M
J Gen Virol; 2004 Sep; 85(Pt 9):2603-2613. PubMed ID: 15302954
[TBL] [Abstract][Full Text] [Related]
27. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
[TBL] [Abstract][Full Text] [Related]
28. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.
Henderson AJ; Calame KL
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8714-9. PubMed ID: 9238043
[TBL] [Abstract][Full Text] [Related]
29. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.
Henderson AJ; Connor RI; Calame KL
Immunity; 1996 Jul; 5(1):91-101. PubMed ID: 8758898
[TBL] [Abstract][Full Text] [Related]
30. Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism.
Lee ES; Zhou H; Henderson AJ
J Virol; 2001 Oct; 75(20):9703-12. PubMed ID: 11559803
[TBL] [Abstract][Full Text] [Related]
31. Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis.
Gold JA; Hoshino Y; Tanaka N; Rom WN; Raju B; Condos R; Weiden MD
Infect Immun; 2004 Feb; 72(2):645-50. PubMed ID: 14742504
[TBL] [Abstract][Full Text] [Related]
32. Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity.
Ravimohan S; Gama L; Engle EL; Zink MC; Clements JE
PLoS One; 2012; 7(8):e42801. PubMed ID: 22952612
[TBL] [Abstract][Full Text] [Related]
33. CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells.
Lee ES; Sarma D; Zhou H; Henderson AJ
Virology; 2002 Jul; 299(1):20-31. PubMed ID: 12167337
[TBL] [Abstract][Full Text] [Related]
34. Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.
Schwartz C; Catez P; Rohr O; Lecestre D; Aunis D; Schaeffer E
J Virol; 2000 Jan; 74(1):65-73. PubMed ID: 10590092
[TBL] [Abstract][Full Text] [Related]
35. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
[TBL] [Abstract][Full Text] [Related]
36. Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes.
Coyle-Rink J; Sweet T; Abraham S; Sawaya B; Batuman O; Khalili K; Amini S
Virology; 2002 Aug; 299(2):240-7. PubMed ID: 12202226
[TBL] [Abstract][Full Text] [Related]
37. CCAAT/enhancer-binding protein beta mediates interferon-gamma-induced p48 (ISGF3-gamma ) gene transcription in human monocytic cells.
Xiao W; Wang L; Yang X; Chen T; Hodge D; Johnson PF; Farrar W
J Biol Chem; 2001 Jun; 276(26):23275-81. PubMed ID: 11312260
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
[TBL] [Abstract][Full Text] [Related]
39. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
